Borderline Tuberculoid Leprosy: An Immune Reconstitution Phenomenon in a Human Immunodeficiency Virus-Infected Person

Lawn, S.D.; Wood, C.; Lockwood, D.N.
January 2003
Clinical Infectious Diseases;1/1/2003, Vol. 36 Issue 1, pe5
Academic Journal
Reports on the development of lesions owing to borderline tuberculoid leprosy in human immunodeficiency virus type-1 infected-patients, kept on active antiretroviral treatment. Association between lesions and changes in lymphocyte count; Suggestion of the role of immune reconstitution.


Related Articles

  • Initial antiretroviral regimens. Carpenter, Charles // BMJ: British Medical Journal (International Edition);3/30/2002, Vol. 324 Issue 7340, p747 

    Editorial. Comments on a study by Rachel Jordan et al of the initial treatment of established HIV infection in adults and adolescents. Indication that three drug antiretroviral regimens are more effective that two drug regimens; Delayed establishment of drug resistance with a three drug...

  • Clinical Evaluation and Management of Metabolic and Morphologic Abnormalities Associated with Human Immunodeficiency Virus. Wanke, Christine A.; Falutz, Julian M.; Shevitz, Abby; Phair, John P.; Kotler, Donald P. // Clinical Infectious Diseases;1/15/2002, Vol. 34 Issue 2, p248 

    In recent years, a spectrum of metabolic and morphologic alterations has emerged among patients infected with human immunodeficiency virus (HIV) receiving antiretroviral treatment. Changes observed include in-sulin resistance, dyslipidemia, abdominal and dorsocervical fat accumulation, and fat...

  • Reservoirs dog AIDS therapy. Smaglik, Paul // Nature;5/18/2000, Vol. 405 Issue 6784, p270 

    Discusses the presence of HIV reservoirs in 'resting' host cells, which are so resilient that researchers doubt the virus can ever be completely eliminated from those infected with HIV. Treatment of HIV with highly active antiretroviral therapy (HAART), which does not eradicate the reservoirs...

  • CD8(sup +) Anti-Human Immunodeficiency Virus Suppressor Activity (CASA) in Response to Antiretroviral Therapy: Loss of CASA Is Associated with Loss of Viremia. Wilkinson, John; Zaunders, John J.; Carr, Andrew; Cooper, David A. // Journal of Infectious Diseases;7/1/99, Vol. 180 Issue 1, p68 

    Analyzes 32 HIV-infected patients receiving mono- or dual therapy for 52 weeks followed by highly active antiretroviral therapy (HAART) for a another 52 weeks. Assessment of T cell number, delayed-type hypersensitivity and plasma HIV RNA in 17 patients with CD8+ anti-human immunodeficiency...

  • HAART PREVENTS CVM PROGRESSION.  // AIDS Patient Care & STDs;Feb2000, Vol. 14 Issue 2, p101 

    Discloses research findings that patients taking highly active antiretroviral therapy (HAART) regimens may be able to stop taking their anti-CMV medications without progression of retinitis. Ability of HAART to rejuvenate the immune system sufficiently enough to control CMV retinitis without...

  • ASHP Statement on the Pharmacist's Role in the Care of Patients with HIV Infection.  // American Journal of Health-System Pharmacy;10/1/2003, Vol. 60 Issue 19, p1998 

    Presents the American Society of Health-System Pharmacists' statement on the pharmacist's role in the care of patients with HIV infection. Position of the organization on the issue; Background information on HIV infection; Responsibilities of pharmacists.

  • Texas surgeon agrees to treat HIV/AIDS patients.  // AIDS Alert;Dec2009, Vol. 24 Issue 12, p139 

    No abstract available.

  • Learn and live: Physicians' HIV experience. Pinkowish, Mary Desmond // Patient Care;5/15/1996, Vol. 30 Issue 9, p18 

    Focuses on the experience of physicians in treating HIV-infected patients as a survival factor in HIV disease. Study of patients with HIV in the Group Health Cooperative of Puget Sound, Washington; Median survival as based on physician experience; Prescription of prophylaxis prior to developing...

  • Massachusetts Provides HIV Services Through Medicaid.  // State Legislatures;May2001, Vol. 27 Issue 5, p6 

    Reports on the coverage and services offered by Medicaid to HIV patients in Massachusetts. Proposal for a state funding to increase the coverage of persons with HIV; Eligibility for Medicaid services; Discussion on the prescription drug coverage stipulated in Medicaid.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics